Table 3.
Pre‐ and postdiagnosis cost savings, prediagnosis cost savings, and incremental savings between MAP and SDLTs
| Cost Year | |||||
|---|---|---|---|---|---|
| Year 1 | Year 2 | Year 3 | Year 4 |
Total (years 1‐4) |
|
| Pre‐ and postdiagnosis direct costs a | |||||
| SDLTs | $16 144 023 | $15 298 148 | $14 941 507 | $14 791 139 | $61 174 818 |
| MAP | $15 488 620 | $14 709 163 | $14 521 010 | $14 464 872 | $59 183 666 |
| Cost savings between MAP and SDLT | $655 403 | $588 985 | $420 497 | $326 267 | $1 991 152 |
| Prediagnosis cost savings between MAP and SDLTs | |||||
| Hospital inpatient visits | $581 728 | $375 056 | $187 089 | $85 341 | $1 229 214 |
| Emergency room visits | $41 354 | $26 662 | $13 300 | $6067 | $87 382 |
| Outpatient office visits | $75 668 | $48 785 | $24 336 | $11 101 | $159 890 |
| Outpatient radiology procedures | $66 422 | $42 824 | $21 362 | $9744 | $140 353 |
| Outpatient lab procedures | −$17 787 | $44 397 | $22 146 | $10 102 | $58 858 |
| Outpatient pharmacy prescriptions | $336 716 | $217 090 | $108 291 | $49 397 | $711 493 |
| Other outpatient costs b | $502 990 | $324 292 | $161 766 | $73 790 | $1 062 839 |
| Incremental savings between MAP and SDLT | |||||
| Prediagnosis | $1 587 091 | $1 079 107 | $538 289 | $245 543 | $3 450 029 |
| Postdiagnosis | −$931 688 | −$490 122 | −$117 792 | $80 724 | −$1 458 877 |
Abbreviations: MAP, multivariate assay panel; SDLT, standard diagnostic laboratory test.
a
Due to the differing sources of pre‐ and postdiagnosis claims data, only prediagnosis costs could be segmented into categories of health services.
b
Top five other outpatient costs by average payment per patient include: dialysis, therapeutic radiology, specialty drugs other than chemotherapy, chemotherapy, and other major breast surgery.